Tumor-mediated immunosuppression and cytokine spreading affects the relation between EMT and PD-L1 status
Epithelial-mesenchymal transition (EMT) and immune resistance mediated by Programmed Death-Ligand 1 (PD-L1) upregulation are established drivers of tumor progression. Their bi-directional crosstalk has been proposed to facilitate tumor immunoevasion, yet the impact of immunosuppression and spatial h...
Uložené v:
| Vydané v: | Frontiers in immunology Ročník 14; s. 1219669 |
|---|---|
| Hlavní autori: | , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Frontiers Media S.A
10.08.2023
|
| Predmet: | |
| ISSN: | 1664-3224, 1664-3224 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Epithelial-mesenchymal transition (EMT) and immune resistance mediated by Programmed Death-Ligand 1 (PD-L1) upregulation are established drivers of tumor progression. Their bi-directional crosstalk has been proposed to facilitate tumor immunoevasion, yet the impact of immunosuppression and spatial heterogeneity on the interplay between these processes remains to be characterized. Here we study the role of these factors using mathematical and spatial models. We first designed models incorporating immunosuppressive effects on T cells mediated
via
PD-L1 and the EMT-inducing cytokine Transforming Growth Factor beta (TGFβ). Our models predict that PD-L1-mediated immunosuppression merely reduces the difference in PD-L1 levels between EMT states, while TGFβ-mediated suppression also causes PD-L1 expression to correlate negatively with TGFβ within each EMT phenotype. We subsequently embedded the models in multi-scale spatial simulations to explicitly describe heterogeneity in cytokine levels and intratumoral heterogeneity. Our multi-scale models show that Interferon gamma (IFNγ)-induced partial EMT of a tumor cell subpopulation can provide some, albeit limited protection to bystander tumor cells. Moreover, our simulations show that the true relationship between EMT status and PD-L1 expression may be hidden at the population level, highlighting the importance of studying EMT and PD-L1 status at the single-cell level. Our findings deepen the understanding of the interactions between EMT and the immune response, which is crucial for developing novel diagnostics and therapeutics for cancer patients. |
|---|---|
| AbstractList | Epithelial-mesenchymal transition (EMT) and immune resistance mediated by Programmed Death-Ligand 1 (PD-L1) upregulation are established drivers of tumor progression. Their bi-directional crosstalk has been proposed to facilitate tumor immunoevasion, yet the impact of immunosuppression and spatial heterogeneity on the interplay between these processes remains to be characterized. Here we study the role of these factors using mathematical and spatial models. We first designed models incorporating immunosuppressive effects on T cells mediated
via
PD-L1 and the EMT-inducing cytokine Transforming Growth Factor beta (TGFβ). Our models predict that PD-L1-mediated immunosuppression merely reduces the difference in PD-L1 levels between EMT states, while TGFβ-mediated suppression also causes PD-L1 expression to correlate negatively with TGFβ within each EMT phenotype. We subsequently embedded the models in multi-scale spatial simulations to explicitly describe heterogeneity in cytokine levels and intratumoral heterogeneity. Our multi-scale models show that Interferon gamma (IFNγ)-induced partial EMT of a tumor cell subpopulation can provide some, albeit limited protection to bystander tumor cells. Moreover, our simulations show that the true relationship between EMT status and PD-L1 expression may be hidden at the population level, highlighting the importance of studying EMT and PD-L1 status at the single-cell level. Our findings deepen the understanding of the interactions between EMT and the immune response, which is crucial for developing novel diagnostics and therapeutics for cancer patients. Epithelial-mesenchymal transition (EMT) and immune resistance mediated by Programmed Death-Ligand 1 (PD-L1) upregulation are established drivers of tumor progression. Their bi-directional crosstalk has been proposed to facilitate tumor immunoevasion, yet the impact of immunosuppression and spatial heterogeneity on the interplay between these processes remains to be characterized. Here we study the role of these factors using mathematical and spatial models. We first designed models incorporating immunosuppressive effects on T cells mediated via PD-L1 and the EMT-inducing cytokine Transforming Growth Factor beta (TGFβ). Our models predict that PD-L1-mediated immunosuppression merely reduces the difference in PD-L1 levels between EMT states, while TGFβ-mediated suppression also causes PD-L1 expression to correlate negatively with TGFβ within each EMT phenotype. We subsequently embedded the models in multi-scale spatial simulations to explicitly describe heterogeneity in cytokine levels and intratumoral heterogeneity. Our multi-scale models show that Interferon gamma (IFNγ)-induced partial EMT of a tumor cell subpopulation can provide some, albeit limited protection to bystander tumor cells. Moreover, our simulations show that the true relationship between EMT status and PD-L1 expression may be hidden at the population level, highlighting the importance of studying EMT and PD-L1 status at the single-cell level. Our findings deepen the understanding of the interactions between EMT and the immune response, which is crucial for developing novel diagnostics and therapeutics for cancer patients. Epithelial-mesenchymal transition (EMT) and immune resistance mediated by Programmed Death-Ligand 1 (PD-L1) upregulation are established drivers of tumor progression. Their bi-directional crosstalk has been proposed to facilitate tumor immunoevasion, yet the impact of immunosuppression and spatial heterogeneity on the interplay between these processes remains to be characterized. Here we study the role of these factors using mathematical and spatial models. We first designed models incorporating immunosuppressive effects on T cells mediated via PD-L1 and the EMT-inducing cytokine Transforming Growth Factor beta (TGFβ). Our models predict that PD-L1-mediated immunosuppression merely reduces the difference in PD-L1 levels between EMT states, while TGFβ-mediated suppression also causes PD-L1 expression to correlate negatively with TGFβ within each EMT phenotype. We subsequently embedded the models in multi-scale spatial simulations to explicitly describe heterogeneity in cytokine levels and intratumoral heterogeneity. Our multi-scale models show that Interferon gamma (IFNγ)-induced partial EMT of a tumor cell subpopulation can provide some, albeit limited protection to bystander tumor cells. Moreover, our simulations show that the true relationship between EMT status and PD-L1 expression may be hidden at the population level, highlighting the importance of studying EMT and PD-L1 status at the single-cell level. Our findings deepen the understanding of the interactions between EMT and the immune response, which is crucial for developing novel diagnostics and therapeutics for cancer patients.Epithelial-mesenchymal transition (EMT) and immune resistance mediated by Programmed Death-Ligand 1 (PD-L1) upregulation are established drivers of tumor progression. Their bi-directional crosstalk has been proposed to facilitate tumor immunoevasion, yet the impact of immunosuppression and spatial heterogeneity on the interplay between these processes remains to be characterized. Here we study the role of these factors using mathematical and spatial models. We first designed models incorporating immunosuppressive effects on T cells mediated via PD-L1 and the EMT-inducing cytokine Transforming Growth Factor beta (TGFβ). Our models predict that PD-L1-mediated immunosuppression merely reduces the difference in PD-L1 levels between EMT states, while TGFβ-mediated suppression also causes PD-L1 expression to correlate negatively with TGFβ within each EMT phenotype. We subsequently embedded the models in multi-scale spatial simulations to explicitly describe heterogeneity in cytokine levels and intratumoral heterogeneity. Our multi-scale models show that Interferon gamma (IFNγ)-induced partial EMT of a tumor cell subpopulation can provide some, albeit limited protection to bystander tumor cells. Moreover, our simulations show that the true relationship between EMT status and PD-L1 expression may be hidden at the population level, highlighting the importance of studying EMT and PD-L1 status at the single-cell level. Our findings deepen the understanding of the interactions between EMT and the immune response, which is crucial for developing novel diagnostics and therapeutics for cancer patients. |
| Author | Lems, Carlijn M. Beltman, Joost B. Burger, Gerhard A. |
| AuthorAffiliation | Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University , Leiden , Netherlands |
| AuthorAffiliation_xml | – name: Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University , Leiden , Netherlands |
| Author_xml | – sequence: 1 givenname: Carlijn M. surname: Lems fullname: Lems, Carlijn M. – sequence: 2 givenname: Gerhard A. surname: Burger fullname: Burger, Gerhard A. – sequence: 3 givenname: Joost B. surname: Beltman fullname: Beltman, Joost B. |
| BookMark | eNp9kU1vFSEYhSemJtbaP-Bqlm7mlq_5WhlTq21yjS6ua_ICL7fUGbgCU9N_L_cjxrqQkEAO5zwQzuvqzAePVfWWkhXnw3hl3TwvK0YYX1FGx64bX1TntOtEwxkTZ3_tX1WXKT2QMsTIOW_PK7dZ5hCbGY2DjKbeo3xIy24XMSUXfA3e1Pophx_OY52KDMb5bQ3Wos6pzvdYR5wg770K8y9EX9982Rxy3z42a1qnDHlJb6qXFqaEl6f1ovr-6WZzfdusv36-u_6wbrQQXW6sEEANipEp5Gq0amBageV2bKG3PaHU9IoUZdSm7wAYMSDK1Mx0nA2WX1R3R64J8CB30c0Qn2QAJw9CiFsJMTs9odSa9qoHogZeAK1S2raGkA46pTqhdWG9P7J2iypfpNHnCNMz6PMT7-7lNjxKSoQYRcsK4d2JEMPPBVOWs0sapwk8hiVJNrSDID0d2mJlR6uOIaWI9s89lMh90fJQtNwXLU9Fl9DwT0i7fCijvMdN_4v-BuvRtZs |
| CitedBy_id | crossref_primary_10_3389_fimmu_2025_1514488 crossref_primary_10_3390_bioengineering12070751 |
| Cites_doi | 10.1159/000512218 10.1038/nrc3239 10.1038/s41467-021-25282-3 10.1038/s43018-023-00570-7 10.1002/jps.3000 10.1016/j.pharmthera.2018.09.007 10.1016/j.smim.2019.05.002 10.1016/j.immuni.2019.03.024 10.1038/cddis.2015.162 10.1038/CDDIS.2017.67 10.1038/s41568-019-0213-x 10.1021/jp403156m 10.1158/2159-8290.CD-21-1059 10.3390/cancers14081864 10.1371/journal.pcbi.1007972 10.3389/fimmu.2016.00668 10.1016/j.it.2006.02.001 10.1016/j.devcel.2019.04.026 10.18632/oncotarget.8166 10.1038/s41467-020-14290-4 10.1103/PhysRevLett.69.2013 10.1038/s41379-018-0124-5 10.1038/nature25501 10.1098/RSOS.220186 10.1016/j.canlet.2019.10.013 10.1073/pnas.1117194109 10.3389/fimmu.2021.797261 10.1016/s0021-9258(18)32439-6 10.1093/bioinformatics/btl485 10.1080/2162402X.2014.1002731 10.1103/PhysRevE.47.2128 10.3389/fimmu.2018.00847 10.1016/j.bpj.2013.07.011 10.1038/ncomms6241 10.1016/j.cell.2016.06.028 10.1038/s43018-020-0036-4 10.1016/j.aca.2017.11.048 10.1093/bioinformatics/btt772 10.1371/journal.pcbi.1004280 10.3389/fbioe.2019.00104 10.1158/0008-5472.CAN-18-3147 10.1016/S0378-4371(03)00574-0 10.1073/pnas.1815345116 10.1016/j.ydbio.2005.10.003 10.1002/1878-0261.12093 10.1016/J.CCR.2007.12.004 10.21105/joss.01686 10.1038/s41580-020-0237-9 10.1371/journal.pcbi.1004206 10.1016/j.bpj.2014.01.048 10.1016/j.bpj.2017.02.008 10.1371/journal.pcbi.1005456 10.4161/onci.21335 10.1016/j.coi.2021.03.016 10.1016/j.isci.2022.104395 10.1016/j.cub.2011.01.067 10.1186/s12943-020-1144-6 10.1084/jem.20041463 10.1016/j.devcel.2021.11.006 10.1126/scisignal.2005304 10.18632/ONCOTARGET 10.1016/J.STEMCR.2013.11.009 10.1080/2162402X.2016.1263412 10.1038/s41598-022-08356-0 10.1016/j.biosystems.2009.12.004 10.1158/1535-7163.MCT-14-0983 10.1186/1752-0509-5-30 10.1038/s43018-020-0038-2 10.1152/ajpcell.00303.2020 10.1016/j.jtbi.2021.110733 10.1084/jem.20061890 10.1084/jem.20060710 10.1016/j.devcel.2019.04.010 |
| ContentType | Journal Article |
| Copyright | Copyright © 2023 Lems, Burger and Beltman. Copyright © 2023 Lems, Burger and Beltman 2023 Lems, Burger and Beltman |
| Copyright_xml | – notice: Copyright © 2023 Lems, Burger and Beltman. – notice: Copyright © 2023 Lems, Burger and Beltman 2023 Lems, Burger and Beltman |
| DBID | AAYXX CITATION 7X8 5PM DOA |
| DOI | 10.3389/fimmu.2023.1219669 |
| DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1664-3224 |
| ExternalDocumentID | oai_doaj_org_article_cc17b7a0b83a4c5bbcf5d006a6bb64cc PMC10449452 10_3389_fimmu_2023_1219669 |
| GrantInformation_xml | – fundername: ; grantid: 864.12.013 |
| GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EBS EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RNS RPM 7X8 5PM |
| ID | FETCH-LOGICAL-c446t-f44a1de492be3b9fb82cbaf3f95a7f7011d7b0baf9cd76aa20da4da4c2d6328f3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 3 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001093662400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1664-3224 |
| IngestDate | Fri Oct 03 12:36:57 EDT 2025 Tue Sep 30 17:11:54 EDT 2025 Thu Sep 04 17:50:54 EDT 2025 Tue Nov 18 22:24:40 EST 2025 Sat Nov 29 05:40:30 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c446t-f44a1de492be3b9fb82cbaf3f95a7f7011d7b0baf9cd76aa20da4da4c2d6328f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Reviewed by: Morgan Craig, University of Montreal, Canada; Marta Canel, University of Edinburgh, United Kingdom Edited by: Heiko Enderling, Moffitt Cancer Center, United States |
| OpenAccessLink | https://doaj.org/article/cc17b7a0b83a4c5bbcf5d006a6bb64cc |
| PQID | 2858407185 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_cc17b7a0b83a4c5bbcf5d006a6bb64cc pubmedcentral_primary_oai_pubmedcentral_nih_gov_10449452 proquest_miscellaneous_2858407185 crossref_primary_10_3389_fimmu_2023_1219669 crossref_citationtrail_10_3389_fimmu_2023_1219669 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-08-10 |
| PublicationDateYYYYMMDD | 2023-08-10 |
| PublicationDate_xml | – month: 08 year: 2023 text: 2023-08-10 day: 10 |
| PublicationDecade | 2020 |
| PublicationTitle | Frontiers in immunology |
| PublicationYear | 2023 |
| Publisher | Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media S.A |
| References | Pramanik (B50) 2021; 524 Gadhamsetty (B62) 2017; 112 Boissonnas (B66) 2007; 204 Burger (B19) 2022; 9 Bruns (B39) 2022; 12 Yang (B2) 2020; 21 Beck (B59) 2020; 16 Ross (B71) 2018; 1000 Benchaib (B43) 2019; 7 Jolly (B24) 2016; 7 Lu (B53) 2013; 117 Martinez-Ciarpaglini (B16) 2019; 32 Chakraborty (B34) 2002; 91 Ouchi (B63) 2003; 329 Batlle (B21) 2019 Jia (B23) 2015; 6 Merks (B67) 2006; 289 Han (B69) 2012; 109 Sahoo (B35) 2021; 12 Niculescu (B64) 2015; 11 Dalal (B28) 1993; 143 Beck (B68) 2019; 79 Wickham (B76) 2019; 4 Chen (B37) 2015; 4 Weigelin (B49) 2021; 12 Tian (B57) 2013; 105 Lu (B5) 2019; 49 Ren (B36) 2020; 19 Boulch (B52) 2023 Chen (B14) 2014; 5 Yang (B27) 2008; 13 Lüönd (B7) 2021; 56 Jenner (B44) 2022; 25 Hanahan (B1) 2022; 12 Bocci (B42) 2019; 116 Thibaut (B31) 2020; 1 Hoekstra (B30) 2020; 1 Terry (B9) 2017; 11 Thurley (B29) 2015; 11 Mrass (B65) 2006; 203 Jiang (B20) 2015; 6 Hoekstra (B32) 2021; 69 Huang (B55) 2017; 13 Whitmire (B45) 2005; 201 Neagu (B58) 2010; 100 Hoops (B72) 2006; 22 Lems (B77) 2023 Williams (B22) 2020; 11 Starruß (B73) 2014; 30 Zitvogel (B12) 2012; 1 Mariathasan (B48) 2018; 554 (B74) 2022 Glazier (B26) 1993; 47 Bhat (B46) 2017; 8 Gadhamsetty (B61) 2017; 7 Castro (B33) 2018; 9 Derynck (B3) 2019; 49 Jolly (B8) 2018; 194 Nieto (B6) 2016; 166 Liu (B41) 2014; 2 Burke (B51) 2019; 43 Pardoll (B10) 2012; 12 Quaiser (B54) 2011; 5 Williams (B4) 2019; 19 Baccarini (B17) 2011; 21 Jonckheere (B47) 2021; 211 Jiang (B13) 2020; 468 (B75) 2020 Graner (B25) 1992; 69 Zhang (B56) 2014; 7 Perez-Oquendo (B40) 2022; 14 Patel (B38) 2015; 14 Kim (B18) 2020; 319 Anderson (B70) 1983; 258 Okazaki (B11) 2006; 27 Noman (B15) 2017; 6 Gadhamsetty (B60) 2014; 106 |
| References_xml | – volume: 211 start-page: 1 year: 2021 ident: B47 article-title: Epithelial-mesenchymal transition (EMT) as a therapeutic target publication-title: Cells Tissues Organs doi: 10.1159/000512218 – volume-title: RStudio: Integrated Development Environment for R year: 2020 ident: B75 – volume: 12 year: 2012 ident: B10 article-title: The blockade of immune checkpoints in cancer immunotherapy publication-title: Nat Rev Cancer doi: 10.1038/nrc3239 – volume-title: lacdr-tox/lems-emt-pdl1-models-figures year: 2023 ident: B77 – volume: 12 start-page: 5217 year: 2021 ident: B49 article-title: Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity publication-title: Nat Commun doi: 10.1038/s41467-021-25282-3 – year: 2023 ident: B52 article-title: Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity publication-title: Nat Cancer doi: 10.1038/s43018-023-00570-7 – volume: 91 year: 2002 ident: B34 article-title: Pharmacodynamic interaction of recombinant human interleukin-10 and prednisolone using in vitro whole blood lymphocyte proliferation publication-title: J Pharm Sci doi: 10.1002/jps.3000 – volume: 194 year: 2018 ident: B8 article-title: Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2018.09.007 – volume: 43 start-page: 101280 year: 2019 ident: B51 article-title: IFN-γ: A cytokine at the right time, is in the right place publication-title: Semin Immunol doi: 10.1016/j.smim.2019.05.002 – year: 2019 ident: B21 article-title: Transforming growth factor- ´ β Signaling in immunity and cancer publication-title: Immunity doi: 10.1016/j.immuni.2019.03.024 – volume: 6 year: 2015 ident: B20 article-title: T-cell exhaustion in the tumor microenvironment publication-title: Cell Death Dis doi: 10.1038/cddis.2015.162 – volume: 143 year: 1993 ident: B28 article-title: Immunocytochemical localization of secreted transforming growth factor-1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma publication-title: Am J Pathol – volume: 8 year: 2017 ident: B46 article-title: Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity publication-title: Cell Death Dis doi: 10.1038/CDDIS.2017.67 – volume: 19 year: 2019 ident: B4 article-title: Controversies around epithelial-mesenchymal plasticity in cancer metastasis publication-title: Nat Rev Cancer doi: 10.1038/s41568-019-0213-x – volume: 117 year: 2013 ident: B53 article-title: Tristability in cancer-associated microRNA-TF chimera toggle switch publication-title: J Phys Chem B doi: 10.1021/jp403156m – volume: 12 start-page: 31 year: 2022 ident: B1 article-title: Hallmarks of cancer: new dimensions publication-title: Cancer Discovery doi: 10.1158/2159-8290.CD-21-1059 – volume: 14 start-page: 1864 year: 2022 ident: B40 article-title: Regulation of ZEB1 function and molecular associations in tumor progression and metastasis publication-title: Cancers doi: 10.3390/cancers14081864 – volume: 16 year: 2020 ident: B59 article-title: Heterogeneous, delayed-onset killing by multiple-hitting T cells: Stochastic simulations to assess methods for analysis of imaging data publication-title: PloS Comput Biol doi: 10.1371/journal.pcbi.1007972 – volume: 7 year: 2017 ident: B61 article-title: Tissue dimensionality influences the functional response of cytotoxic T lymphocyte-mediated killing of targets publication-title: Front Immunol doi: 10.3389/fimmu.2016.00668 – volume: 27 start-page: 195 year: 2006 ident: B11 article-title: The PD-1-PD-L pathway in immunological tolerance publication-title: Trends Immunol doi: 10.1016/j.it.2006.02.001 – volume: 49 year: 2019 ident: B3 article-title: EMT and cancer: more than meets the eye publication-title: Dev Cell doi: 10.1016/j.devcel.2019.04.026 – volume: 7 year: 2016 ident: B24 article-title: Stability of the hybrid epithelial/mesenchymal phenotype publication-title: Oncotarget doi: 10.18632/oncotarget.8166 – volume: 11 start-page: 1 year: 2020 ident: B22 article-title: Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-γ-signaling mutant cancer cells publication-title: Nat Commun doi: 10.1038/s41467-020-14290-4 – volume: 69 year: 1992 ident: B25 article-title: Simulation of biological cell sorting using a two-dimensional extended Potts model publication-title: Phys Rev Lett doi: 10.1103/PhysRevLett.69.2013 – volume: 32 year: 2019 ident: B16 article-title: Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression publication-title: Modern Pathol doi: 10.1038/s41379-018-0124-5 – volume: 554 year: 2018 ident: B48 article-title: TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells publication-title: Nature doi: 10.1038/nature25501 – volume: 9 start-page: 220186 year: 2022 ident: B19 article-title: Bidirectional crosstalk between epithelial-mesenchymal plasticity and IFNγ-induced PD-L1 expression promotes tumour progression publication-title: R Soc Open Sci doi: 10.1098/RSOS.220186 – volume: 468 start-page: 72 year: 2020 ident: B13 article-title: Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion publication-title: Cancer Lett doi: 10.1016/j.canlet.2019.10.013 – volume: 109 year: 2012 ident: B69 article-title: Polyfunctional responses by human T cells result from sequential release of cytokines publication-title: Proc Natl Acad Sci United States America doi: 10.1073/pnas.1117194109 – volume: 12 year: 2021 ident: B35 article-title: Immunosuppressive traits of the hybrid epithelial/mesenchymal phenotype publication-title: Front Immunol doi: 10.3389/fimmu.2021.797261 – volume: 258 year: 1983 ident: B70 article-title: Human interferon-γ is internalized and degraded by cultured fibroblasts publication-title: J Biol Chem doi: 10.1016/s0021-9258(18)32439-6 – volume: 22 year: 2006 ident: B72 article-title: COPASI–a complex pathway simulator publication-title: Bioinformatics doi: 10.1093/bioinformatics/btl485 – volume: 4 year: 2015 ident: B37 article-title: The mutually regulatory loop of epithelial- mesenchymal transition and immunosuppression in cancer progression publication-title: OncoImmunology doi: 10.1080/2162402X.2014.1002731 – volume-title: R: A language and environment for statistical computing year: 2022 ident: B74 – volume: 47 year: 1993 ident: B26 article-title: Simulation of the differential adhesion driven rearrangement of biological cells publication-title: Phys Rev E doi: 10.1103/PhysRevE.47.2128 – volume: 9 year: 2018 ident: B33 article-title: Interferon-gamma at the crossroads of tumor immune surveillance or evasion publication-title: Front Immunol doi: 10.3389/fimmu.2018.00847 – volume: 105 year: 2013 ident: B57 article-title: Coupled reversible and irreversible bistable switches underlying TGFβ-induced epithelial to mesenchymal transition publication-title: Biophys J doi: 10.1016/j.bpj.2013.07.011 – volume: 5 start-page: 5241 year: 2014 ident: B14 article-title: Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression publication-title: Nat Commun doi: 10.1038/ncomms6241 – volume: 166 start-page: 21 year: 2016 ident: B6 article-title: EMT: 2016 publication-title: Cell doi: 10.1016/j.cell.2016.06.028 – volume: 1 start-page: 291 year: 2020 ident: B30 article-title: Long-distance modulation of bystander tumor cells by CD8+ T-cell-secreted IFN-γ publication-title: Nat Cancer doi: 10.1038/s43018-020-0036-4 – volume: 1000 year: 2018 ident: B71 article-title: Diffusion of cytokines in live lymph node tissue using microfluidic integrated optical imaging publication-title: Analytica Chimica Acta doi: 10.1016/j.aca.2017.11.048 – volume: 30 year: 2014 ident: B73 article-title: Morpheus: A user-friendly modeling environment for multiscale and multicellular systems biology publication-title: Bioinformatics doi: 10.1093/bioinformatics/btt772 – volume: 11 year: 2015 ident: B64 article-title: Crawling and gliding: a computational model for shape-driven cell migration publication-title: PloS Comput Biol doi: 10.1371/journal.pcbi.1004280 – volume: 7 year: 2019 ident: B43 article-title: Mathematical modeling reveals that the administration of EGF can promote the elimination of lymph node metastases by PD-1/PD-L1 blockade publication-title: Front Bioengineering Biotechnol doi: 10.3389/fbioe.2019.00104 – volume: 79 year: 2019 ident: B68 article-title: Contact-dependent killing by cytotoxic T lymphocytes is insufficient for EL4 tumor regression in vivo publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-18-3147 – volume: 329 year: 2003 ident: B63 article-title: Improving the realism of the cellular Potts model in simulations of biological cells publication-title: Physica A: Stat Mechanics its Appl doi: 10.1016/S0378-4371(03)00574-0 – volume: 116 year: 2019 ident: B42 article-title: Toward understanding cancer stem cell heterogeneity in the tumor microenvironment publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.1815345116 – volume: 289 start-page: 44 year: 2006 ident: B67 article-title: Cell elongation is key to in silico replication of in vitro vasculogenesis and subsequent remodeling publication-title: Dev Biol doi: 10.1016/j.ydbio.2005.10.003 – volume: 11 year: 2017 ident: B9 article-title: New insights into the role of EMT in tumor immune escape publication-title: Mol Oncol doi: 10.1002/1878-0261.12093 – volume: 13 start-page: 23 year: 2008 ident: B27 article-title: Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis publication-title: Cancer Cell doi: 10.1016/J.CCR.2007.12.004 – volume: 4 start-page: 1686 year: 2019 ident: B76 article-title: Welcome to the tidyverse publication-title: J of Open Source Software doi: 10.21105/joss.01686 – volume: 21 year: 2020 ident: B2 article-title: Guidelines and definitions for research on epithelial-mesenchymal transition publication-title: Nat Rev Mol Cell Biol doi: 10.1038/s41580-020-0237-9 – volume: 11 start-page: 1 year: 2015 ident: B29 article-title: Three-dimensional gradients of cytokine signaling between T cells publication-title: PloS Comput Biol doi: 10.1371/journal.pcbi.1004206 – volume: 106 year: 2014 ident: B60 article-title: A general functional response of cytotoxic T lymphocyte-mediated killing of target cells publication-title: Biophys J doi: 10.1016/j.bpj.2014.01.048 – volume: 112 year: 2017 ident: B62 article-title: A sigmoid functional response emerges when cytotoxic T lymphocytes start killing fresh target cells publication-title: Biophys J doi: 10.1016/j.bpj.2017.02.008 – volume: 13 start-page: 1 year: 2017 ident: B55 article-title: Interrogating the topological robustness of gene regulatory circuits by randomization publication-title: PloS Comput Biol doi: 10.1371/journal.pcbi.1005456 – volume: 1 year: 2012 ident: B12 article-title: Targeting PD-1/PD-L1 interactions for cancer immunotherapy publication-title: OncoImmunology doi: 10.4161/onci.21335 – volume: 69 start-page: 65 year: 2021 ident: B32 article-title: Modulation of the tumor micro-environment by CD8+ T cell-derived cytokines publication-title: Curr Opin Immunol doi: 10.1016/j.coi.2021.03.016 – volume: 25 start-page: 104395 year: 2022 ident: B44 article-title: Agent-based computational modeling of glioblastoma predicts that stromal density is central to oncolytic virus efficacy publication-title: iScience doi: 10.1016/j.isci.2022.104395 – volume: 21 year: 2011 ident: B17 article-title: Kinetic analysis reveals the fate of a microRNA following target regulation in mammalian cells publication-title: Curr Biol doi: 10.1016/j.cub.2011.01.067 – volume: 19 start-page: 19 year: 2020 ident: B36 article-title: Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy publication-title: Mol Cancer doi: 10.1186/s12943-020-1144-6 – volume: 201 year: 2005 ident: B45 article-title: Interferon-γ acts directly on CD8+ T cells to increase their abundance during virus infection publication-title: J Exp Med doi: 10.1084/jem.20041463 – volume: 56 year: 2021 ident: B7 article-title: Distinct contributions of partial and full EMT to breast cancer malignancy publication-title: Dev Cell doi: 10.1016/j.devcel.2021.11.006 – volume: 7 start-page: ra91 year: 2014 ident: B56 article-title: TGF-β-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops publication-title: Sci Signaling doi: 10.1126/scisignal.2005304 – volume: 6 year: 2015 ident: B23 article-title: OVOL guides the epithelial-hybrid-mesenchymal transition publication-title: Oncotarget doi: 10.18632/ONCOTARGET – volume: 2 start-page: 78 year: 2014 ident: B41 article-title: Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts publication-title: Stem Cell Rep doi: 10.1016/J.STEMCR.2013.11.009 – volume: 6 year: 2017 ident: B15 article-title: The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200 publication-title: OncoImmunology doi: 10.1080/2162402X.2016.1263412 – volume: 12 start-page: 1 year: 2022 ident: B39 article-title: Quantifying the contribution of transcription factor activity, mutations and microRNAs to CD274 expression in cancer patients publication-title: Sci Rep doi: 10.1038/s41598-022-08356-0 – volume: 100 start-page: 23 year: 2010 ident: B58 article-title: Computational modeling of epithelial-mesenchymal transformations publication-title: BioSystems doi: 10.1016/j.biosystems.2009.12.004 – volume: 14 year: 2015 ident: B38 article-title: PD-L1 expression as a predictive biomarker in cancer immunotherapy publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-14-0983 – volume: 5 year: 2011 ident: B54 article-title: A simple work flow for biologically inspired model reduction - application to early JAK-STAT signaling publication-title: BMC Syst Biol doi: 10.1186/1752-0509-5-30 – volume: 1 year: 2020 ident: B31 article-title: Bystander IFN-γ activity promotes widespread and sustained cytokine signaling altering the tumor microenvironment publication-title: Nat Cancer doi: 10.1038/s43018-020-0038-2 – volume: 319 year: 2020 ident: B18 article-title: miRNA degradation in the mammalian brain publication-title: Am J Physiol Cell Physiol doi: 10.1152/ajpcell.00303.2020 – volume: 524 start-page: 110733 year: 2021 ident: B50 article-title: Matrix adhesion and remodeling diversifies modes of cancer invasion across spatial scales publication-title: J Theor Biol doi: 10.1016/j.jtbi.2021.110733 – volume: 204 year: 2007 ident: B66 article-title: In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor publication-title: J Exp Med doi: 10.1084/jem.20061890 – volume: 203 year: 2006 ident: B65 article-title: Random migration precedes stable target cell interactions of tumor-infiltrating T cells publication-title: J Exp Med doi: 10.1084/jem.20060710 – volume: 49 year: 2019 ident: B5 article-title: Epithelial-mesenchymal plasticity in cancer progression and metastasis publication-title: Dev Cell doi: 10.1016/j.devcel.2019.04.010 |
| SSID | ssj0000493335 |
| Score | 2.3647773 |
| Snippet | Epithelial-mesenchymal transition (EMT) and immune resistance mediated by Programmed Death-Ligand 1 (PD-L1) upregulation are established drivers of tumor... |
| SourceID | doaj pubmedcentral proquest crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
| StartPage | 1219669 |
| SubjectTerms | cellular Potts model epithelial-mesenchymal transition (EMT) immunoevasion Immunology ordinary differential equations PD-L1 |
| Title | Tumor-mediated immunosuppression and cytokine spreading affects the relation between EMT and PD-L1 status |
| URI | https://www.proquest.com/docview/2858407185 https://pubmed.ncbi.nlm.nih.gov/PMC10449452 https://doaj.org/article/cc17b7a0b83a4c5bbcf5d006a6bb64cc |
| Volume | 14 |
| WOSCitedRecordID | wos001093662400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1664-3224 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000493335 issn: 1664-3224 databaseCode: DOA dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1664-3224 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000493335 issn: 1664-3224 databaseCode: M~E dateStart: 20100101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9QwFA-6KHgRP3H8WCJ4k7htkzTJ0Y9ZPLjLHkaYW0leEhx12mU6Ffbi3-5L2l2mF70IpYc0IenLS_P70ZffI-QNMh1XOuGZqoAzoR1nDvdRxsHFuorOiRJysgl1fq7Xa3NxkOorxYSN8sCj4U4ASuWULZzmVoB0DqL06Cq2dq4WAOnrWyhzQKa-j7iXcy7HUzLIwsxJ3Gy3w7uULDwJKiDIN7OdKAv2z1DmPEbyYNM5fUDuT2iRvh9H-ZDcCu0jcnfMH3n1mGxWw7bbsXz6A5EjTZ23XT9cTtGtLbWtp3C1734gmKQ9FueQeWrHKA6K6I_upnA4OoVs0eXZKre7-MS-lDSdOBr6J-Tr6XL18TObcicwQIK3Z1EIW_ogTOUCdyY6XYGzkUcjrYoKV7VXrsASA17V1laFtwIvqHzNKx35U3LUdm14RmhhkCXjsi0AqZsMwWoOtRRBCy-AS78g5bUdG5iExVN-i58NEoxk-ybbvkm2bybbL8jbmzaXo6zGX2t_SNNzUzNJYucCdJRmcpTmX46yIK-vJ7fBJZT-i9g2dEPfVBpRGEItLRdEz2Z91uP8Sbv5lsW40SbCCFk9_x9jfEHupfdmWXL3JTna74bwityBX_tNvzsmt9VaH2dHx_vZ7-Uf1d8JNA |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tumor-mediated+immunosuppression+and+cytokine+spreading+affects+the+relation+between+EMT+and+PD-L1+status&rft.jtitle=Frontiers+in+immunology&rft.au=Lems%2C+Carlijn+M.&rft.au=Burger%2C+Gerhard+A.&rft.au=Beltman%2C+Joost+B.&rft.date=2023-08-10&rft.pub=Frontiers+Media+S.A&rft.eissn=1664-3224&rft.volume=14&rft_id=info:doi/10.3389%2Ffimmu.2023.1219669&rft.externalDocID=PMC10449452 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon |